Rosetta Genomics Closes on Public Offering, Raises $27.5M
August 08, 2012
Rosetta Genomics Closes on Public Offering, Raises $27.5M
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Underwriters Exercise Option on Rosetta Public Offering; Total Gross Proceeds Rise to $31.6M
August 29, 2012 / GenomeWeb Daily News - Rosetta to Offer $35M in Public Offering, Receives NYS Approval for Lung Cancer Assay
June 26, 2012 / GenomeWeb Daily News - Rosetta Genomics, Prime Health Reach Deal for Coverage of MiRview Mets2 Assay
May 20, 2013 / GenomeWeb Daily News - Sanra Labs Makes Full Payment to Rosetta Genomics, Settling Dispute
May 10, 2013 / GenomeWeb Daily News - Rosetta Releases miRview Kidney Test Validation Study, Anticipates Medicare Coverage Decision
April 4, 2013 / Gene Silencing News